Efficacy and safety of FOLFIRINOX in advanced cholangiocarcinoma.

被引：2
|
作者：
Kim, Byung Moon
Armenio, Vincent Anthony
机构：
[1] Roger Williams Med Ctr, Warwick, RI USA
[2] Boston Univ, Roger Williams Med Ctr, Providence, RI USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.e15620
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e15620
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Efficacy and safety of FOLFIRINOX in elderly patients with advanced pancreatic adenocarcinoma.
    Jung, Jae Hyup
    Kang, Jingu
    Lee, Jong-Chan
    Hwang, Jin-Hyeok
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [2] Comparison of neoadjuvant treatment modalities for locally advanced intrahepatic cholangiocarcinoma.
    Garita, Esteban
    Tahir, Muhammad Mohid
    Sucre, Santiago
    Juarez, Juan Jose
    Peters, Mary Linton Bounetheau
    Sarwar, Ammar
    Bullock, Andrea J.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 510 - 510
  • [3] Efficacy and Safety of Apatinib Treatment for Patients with Advanced Intrahepatic Cholangiocarcinoma
    Lin, Guohe
    Wang, Bicheng
    Wu, Xiuwei
    Sun, Tong
    Chen, Lili
    Lu, Canliang
    Wang, Nianfei
    CANCER MANAGEMENT AND RESEARCH, 2020, 12 : 11523 - 11526
  • [4] Combined hepatocellular and cholangiocarcinoma.
    Dondero, F
    Regimbeau, JM
    Cazals-Hatem, D
    Terris, B
    Flejou, JF
    Degott, C
    Belghiti, J
    HEPATOLOGY, 2001, 34 (04) : 669A - 669A
  • [5] Efficacy and safety of immune checkpoint inhibitors in patients with advanced intrahepatic cholangiocarcinoma
    Peng, Ziting
    Dong, Jianhui
    Tang, Shuyao
    Shi, Jiaxu
    Shi, Tongdong
    FRONTIERS IN ONCOLOGY, 2025, 15
  • [6] SYSTEMATIC LITERATURE REVIEW OF THE EFFICACY AND SAFETY OF INFIGRATINIB FOR THE TREATMENT OF ADVANCED CHOLANGIOCARCINOMA
    Veeranki, P.
    Nadimpally, J.
    Mir, J.
    Sharma, S.
    Kohli, I. S.
    Rajput, A.
    Goyal, R.
    Kamra, S.
    VALUE IN HEALTH, 2022, 25 (07) : S333 - S333
  • [7] Controversial risk factors for cholangiocarcinoma.
    Sarmini, Muhammad Talal
    Baidoun, Firas
    Saad, Anas M.
    Gad, Mohamed
    Moustafa, Muhamad Alhaj
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [8] Effect of AdipoR agonist in cholangiocarcinoma.
    Bui, Khac Cuong
    Nguyen, Mai Ly Thi
    Barat, Samarpita
    Chen, Xi
    Bhuria, Vikas
    Xing, Jun
    Nguyen, Linh Toan
    Le, Huu Song
    Velavan, Thirumalaisamy P.
    Wilkens, Ludwig
    Malek, Nisar P.
    Bozko, Przemyslaw
    Plentz, Ruben R.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [9] Hepatolithiasis associated with intrahepatic cholangiocarcinoma.
    Sato, M
    Yamamoto, T
    Watanabe, Y
    Iseki, S
    Sato, N
    Kimura, S
    GASTROENTEROLOGY, 1996, 110 (04) : A1312 - A1312
  • [10] Mismatch repair deficiency in cholangiocarcinoma.
    Kunk, Paul Raymond
    Obeid, Joseph Mounir
    Winters, Kevin
    Pramoonjago, Patcharin
    Brockstedt, Dirk G.
    Giobbie-Hurder, Anita
    Stelow, Edward B.
    Bauer, Todd W.
    Slingluff, Craig L.
    Rahma, Osama E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
12345